The effect of using an exacerbation management program in COPD patients with Gold D stage at Bangpakong Hospital, Chachoengsao Province.

Abstract

     This study studied the effects of using a program for managing exacerbations in COPD patients in Gold D stage at Bangpakong Hospital, Chachoengsao Province. This was a quasi-experimental research. The objective of the study was to study the effects of using a program for managing exacerbations in COPD patients in Gold D stage at Bangpakong Hospital, Chachoengsao Province. The sample consisted of patients diagnosed with COPD by a physician, with ICD-10 code J440-J449 as the primary disease in the medical records registered at Bangpakong Hospital, and who were in Gold D stage and receiving treatment. The researcher selected purposive sampling who received services at the special clinic, Bangpakong Hospital, Chachoengsao Province, totaling 20 patients. The experimental instrument was qualified according to the inclusion criteria according to the specified qualifications. The experimental instrument was a program for managing exacerbations in COPD patients in Gold D stage, which was created by the researcher based on Gibson’s empowerment concept and the concept of self-awareness. (self-awareness) and the tools used in collecting data were the disease severity and control assessment form according to Appendix 1, which has 7 items in total, and Appendix 2, which has 8 items in total, and the anxiety assessment and analysis questionnaire, which has 7 items in total. Data were analyzed using content analysis, statistics, percentages, means, standard deviations, and paired t-test.

     The research results found that 1) After receiving the program for managing asthma exacerbations in COPD patients, Gold D stage, Bangpakong Hospital, Chachoengsao Province, the incidence of acute exacerbations was significantly reduced compared to before receiving the program at a statistical level of <0.05. 2) After receiving the program for managing asthma exacerbations in COPD patients, Gold D stage, Bangpakong Hospital, Chachoengsao Province, anxiety about symptoms and severity of the disease was significantly reduced compared to before receiving the program at a statistical level of <0.05. 3) The indicators of COPD patients in 2022 passed all criteria, which were as follows: 1) The COPD Revisit rate within 48 hours decreased in 2021 from 3.50 percent in 2022 to 0.75 percent. 2) The COPD Readmit rate within 28 days decreased in 2021 from 17.16 percent in 2023 to 4.77 percent.